To all those who are concerned that they might be a victim of Corona Virus and are in a panic situation on whom to approach and what to do to confirm the infection, here’s some good news.
Researchers from Carnegie Mellon University have developed an Artificial Intelligence-based app that analyzes the voice of a user and tells them if they are infected by the Novel COVID 19 Virus.
According to the details available with Cybersecurity Insiders, the app picks up the breathing patterns and other parameters of the user and then matches it with huge data sets to confirm whether the virus has infected the lungs of a user.
The only bad news is that the app is still in the testing phase and needs a lot of voice recording data from infected Coronavirus patients to improve the algorithm- thus improving its efficacy.
Dubbed as COVID Voice Detector, this AI-powered app doesn’t come with the approval from FDA or CDC and so should not be used in place of medical tests or examinations.
With more than 40,000 deaths around the globe and infecting more than 900,000(appx) positive cases, the said virus which emerged from Wuhan, China in November 2019 has been labeled as the deadliest infection in the history of the world. And in the wake of shortage of test kits, the new app can reduce the burden on the healthcare, if it comes up as efficient as seen on paper.
Note– To all those who have lost the hope at the end of Corona Virus spread, here’s some good news. Fujifilm’s Pharmaceutical branch has started its phase 3 test trials of its Avigan (Favipiravir) drug from Tuesday to those infected with COVID 19 in Japan. It is reported that the drug stands as a one-shot antiviral drug solution against 18 types of flu and might prove effective getting rid of Corona Pandemic from the infected nations. So, the clinical trials made on the infected people in Japan have yielded excellent results and have already clinically proven by experts that it can eradicate the Ebola Virus to the core. Already Fujifilm has ramped its production in March 2020 after it started its trials in November 2019 after seeing the spread of the Wuhan Virus in China.
Let’s hope for the best!
